New York Life Investment Management LLC Uni Qure N.V. Transaction History

New York Life Investment Management LLC

  • $9.63 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
BUY
$18.12 - $27.32 $60,991 - $91,959
3,366 Added 12.01%
31,391 $711,000
Q3 2022

Nov 10, 2022
BUY
$16.98 - $25.54 $37,661 - $56,647
2,218 Added 8.59%
28,025 $526,000
Q2 2022

Aug 12, 2022
BUY
$13.15 - $20.45 $339,362 - $527,753
25,807 New
25,807 $481,000

Others Institutions Holding QURE

# of Institutions
153
Shares Held
41M
Call Options Held
925K
Put Options Held
617K
View Full List

About uniQure N.V.

QURE Quotes by TradingView
  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $270M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track New York Life Investment Management LLC Portfolio

Follow New York Life Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on New York Life Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email